Skip to main content
MedPath Trial logoMedPath TrialMedPath Trial Home
Clinical Trials/NCT00323180
NCT00323180WithdrawnNot Applicable

Investigation of Protein Biomarkers of Prostate Cancer

University of New Mexico1 site in 1 countryStarted: August 2005Last updated:
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Withdrawn
Locations
1
Study OverviewStudy DesignEligibility CriteriaInvestigatorsSitesRecords & IdentifiersSimilar Trials

Study Overview

Brief Summary

This study is looking at biomarkers in prostate cancer.

Detailed Description

  1. To establish primary culture of epithelial cells isolated from prostatectomy samples
  2. To study biomarkers in prostate cancer

Study Design

Study Type
Observational
Observational Model
Other
Time Perspective
Prospective

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
Male
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •Patients with prostate cancer.

Exclusion Criteria

  • Not provided

Investigators

Sponsor Class
Other

Study Sites (1)

Loading locations...

Similar Trials

Recruiting
Not Applicable
Predictive and Prognostic Markers for Treatment Outcomes in Prostate Cancer PatientsProstate Cancer
NCT03237026National Taiwan University Hospital360
Withdrawn
Not Applicable
Investigation of Urinary Biomarkers for the Detection of Prostate CancerUrineLiquid BiopsyProstate Cancer
NCT05454371Novosanis NV
Unknown
Not Applicable
Analysis of a New Biomarker for Prostate Cancer DiagnosisPatients With Suspected Prostate Cancer
NCT01819740Corporacion Parc Tauli28
Completed
Not Applicable
Prostate Cancer Upgrading Reference SetProstate Cancer
NCT02189486The University of Texas Health Science Center at San Antonio382
Completed
Not Applicable
Validation of the Stockholm3 Test for Detection of Prostate Cancer in the Swiss PopulationLocalized CarcinomaProstate Cancer
NCT05294627University Hospital, Basel, Switzerland380